2SEVENTY BIO INC (TSVT)
US9013841070 - Common Stock
ChartMill assigns a Buy % Consensus number of 77% to TSVT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.71. This target is 120.37% above the current price.
TSVT was analyzed by 14 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about TSVT.
In the previous month the buy percentage consensus was at a similar level.
TSVT was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-08 | Citigroup | Maintains | Buy -> Buy |
| 2024-03-18 | Wedbush | Reiterate | Neutral -> Neutral |
| 2024-01-31 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2024-01-31 | TD Cowen | Downgrade | Outperform -> Market Perform |
| 2023-11-20 | Wedbush | Downgrade | Outperform -> Neutral |
| 2023-10-30 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2023-10-12 | Citigroup | Initiate | Buy |
| 2023-09-13 | Guggenheim | Downgrade | Buy -> Neutral |
| 2023-09-13 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2023-09-12 | Guggenheim | Downgrade | Buy -> Neutral |
| 2023-08-15 | Guggenheim | Maintains | Buy -> Buy |
| 2023-08-15 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-07-28 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-07-28 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2023-07-20 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-05-18 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-05-15 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-03-17 | Wedbush | Maintains | Outperform |
| 2023-01-24 | Morgan Stanley | Maintains | Overweight |
| 2023-01-20 | Goldman Sachs | Maintains | Buy |
| 2023-01-10 | SVB Leerink | Maintains | Outperform |
| 2022-11-08 | SVB Leerink | Maintains | Outperform |
| 2022-11-08 | Morgan Stanley | Maintains | Overweight |
| 2022-10-31 | Guggenheim | Initiate | Buy |
| 2022-08-15 | Morgan Stanley | Maintains | Overweight |
| 2022-07-15 | Morgan Stanley | Maintains | Overweight |
| 2022-05-17 | Morgan Stanley | Maintains | Overweight |
| 2022-05-02 | Goldman Sachs | Initiate | Buy |
| 2022-02-10 | SVB Leerink | Initiate | Outperform |
| 2022-01-06 | Cowen & Co. | Initiate | Outperform |